Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study

Thaker, 2001, Advances in schizophrenia, Nat Med, 7, 667, 10.1038/89040 Huber, 2008, Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors, Exper Opin Pharmacother, 9, 2027, 10.1517/14656566.9.12.2027 Lieberman, 2007, Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials, J Clin Psychiatry, 68, e04, 10.4088/JCP.0207e04 Ilyas, 2012, Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010, Br J Psychiatry, 200, 393, 10.1192/bjp.bp.111.104257 Arranz, 2007, Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research, Mol Psychiatry, 12, 707, 10.1038/sj.mp.4002009 Zhang, 2011, Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction, Exper Opin Drug Metabol Toxicol, 7, 9, 10.1517/17425255.2011.532787 Lavedan, 2009, Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study, Mol Psychiatry, 14, 804, 10.1038/mp.2008.56 Clark, 2013, Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment, Pharmacogenet Genomics, 23, 69, 10.1097/FPC.0b013e32835ca260 Drago, 2014, Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment, Pharmacogenet Genomics, 24, 314, 10.1097/FPC.0000000000000052 Li, 2017, Genome-wide association study of paliperidone efficacy, Pharmacogenet Genomics, 27, 7, 10.1097/FPC.0000000000000250 Sacchetti, 2017, The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis, Pharmacogenomics J, 17, 146, 10.1038/tpj.2015.90 Li, 2017, Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes, Schizophr Res Stevenson, 2016, Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes, Transl Psychiatry, 6, e739, 10.1038/tp.2016.10 McClay, 2011, Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics, Mol Psychiatry, 16, 76, 10.1038/mp.2009.89 Agid, 2003, Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected, Arch Gen Psychiatry, 60, 1228, 10.1001/archpsyc.60.12.1228 Leucht, 2005, Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended, Biol Psychiatry, 57, 1543, 10.1016/j.biopsych.2005.02.023 Kinon, 2010, Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia, Neuropsychopharmacology, 35, 581, 10.1038/npp.2009.164 Price, 2006, Principal components analysis corrects for stratification in genome-wide association studies, Nat Genet, 38, 904, 10.1038/ng1847 Obermeier, 2010, Should the PANSS be rescaled?, Schizophr Bull, 3, 455, 10.1093/schbul/sbp124 Delaneau, 2013, Improved whole-chromosome phasing for disease and population genetic studies, Nat Methods, 10, 5, 10.1038/nmeth.2307 Howie, 2009, A flexible and accurate genotype imputation method for the next generation of genome-wide association studies, PLoS Genet, 5, e1000529, 10.1371/journal.pgen.1000529 Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses, Am J Hum Genet, 81, 559, 10.1086/519795 Kanai, 2016, Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set, J Hum Genet, 61, 861, 10.1038/jhg.2016.72 De Bakker, 2008, Practical aspects of imputation-driven meta-analysis of genome-wide association studies, Hum Mol Genet, 17, R122, 10.1093/hmg/ddn288 Yang, 2011, GCTA: a tool for genome-wide complex trait analysis, Am J Hum Genet, 88, 76, 10.1016/j.ajhg.2010.11.011 Consortium, 2015, Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans, Science, 348, 648, 10.1126/science.1262110 Ramasamy, 2014, Genetic variability in the regulation of gene expression in ten regions of the human brain, Nat Neurosci, 17, 1418, 10.1038/nn.3801 Kichaev, 2014, Integrating functional data to prioritize causal variants in statistical fine-mapping studies, PLoS Genet, 10, e1004722, 10.1371/journal.pgen.1004722 Gauderman, 2003, Candidate gene association analysis for a quantitative trait, using parent–offspring trios, Genet Epidemiol, 25, 327, 10.1002/gepi.10262 Traut, 2006, New members of the neurexin superfamily: multiple rodent homologues of the human CASPR5 gene, Mamm Genome, 17, 723, 10.1007/s00335-005-0157-1 Poliak, 2003, The local differentiation of myelinated axons at nodes of Ranvier, Nat Rev Neurosci, 4, 968, 10.1038/nrn1253 Awasaki, 2006, Essential role of the apoptotic cell engulfment genes draper and ced-6 in programmed axon pruning during Drosophila metamorphosis, Neuron, 50, 855, 10.1016/j.neuron.2006.04.027 Chung, 2013, Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways, Nature, 504, 394, 10.1038/nature12776 Yoshida, 1998, Cloning, expression analysis, and chromosomal localization of BH-protocadherin (PCDH7), a novel member of the cadherin superfamily, Genomics, 49, 458, 10.1006/geno.1998.5271 Ouimet, 1995, The alpha and gamma 1 isoforms of protein phosphatase 1 are highly and specifically concentrated in dendritic spines, Proc Natl Acad Sci USA, 92, 3396, 10.1073/pnas.92.8.3396 Mahmoudi, 2009, The kinase TNIK is an essential activator of Wnt target genes, EMBO J, 28, 3329, 10.1038/emboj.2009.285 MacLaren, 2011, Knockdown of mental disorder susceptibility genes disrupts neuronal network physiology in vitro, Mol Cell Neurosci, 47, 93, 10.1016/j.mcn.2010.12.014 Wang, 2011, The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function, Mol Psychiatry, 16, 1006, 10.1038/mp.2010.87 Aoyama, 2006, Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse, Nat Neurosci, 9, 119, 10.1038/nn1609 Schmitt, 2003, Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain, Neurosci Lett, 347, 81, 10.1016/S0304-3940(03)00653-0 Miyamoto, 2005, Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs, Mol Psychiatry, 10, 79, 10.1038/sj.mp.4001556 2014, Biological insights from 108 schizophrenia-associated genetic loci, Nature, 511, 421, 10.1038/nature13595